JP2010529212A5 - - Google Patents

Download PDF

Info

Publication number
JP2010529212A5
JP2010529212A5 JP2009551999A JP2009551999A JP2010529212A5 JP 2010529212 A5 JP2010529212 A5 JP 2010529212A5 JP 2009551999 A JP2009551999 A JP 2009551999A JP 2009551999 A JP2009551999 A JP 2009551999A JP 2010529212 A5 JP2010529212 A5 JP 2010529212A5
Authority
JP
Japan
Prior art keywords
poz
compound
group
functional group
active functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009551999A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010529212A (ja
JP5615558B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/002626 external-priority patent/WO2008106186A2/en
Publication of JP2010529212A publication Critical patent/JP2010529212A/ja
Publication of JP2010529212A5 publication Critical patent/JP2010529212A5/ja
Application granted granted Critical
Publication of JP5615558B2 publication Critical patent/JP5615558B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009551999A 2007-02-28 2008-02-28 活性ポリオキサゾリンおよびそれを含む組成物 Active JP5615558B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89221207P 2007-02-28 2007-02-28
US60/892,212 2007-02-28
PCT/US2008/002626 WO2008106186A2 (en) 2007-02-28 2008-02-28 Activated polyoxazolines and compositions comprising the same

Publications (3)

Publication Number Publication Date
JP2010529212A JP2010529212A (ja) 2010-08-26
JP2010529212A5 true JP2010529212A5 (cg-RX-API-DMAC7.html) 2011-04-07
JP5615558B2 JP5615558B2 (ja) 2014-10-29

Family

ID=39721806

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009551999A Active JP5615558B2 (ja) 2007-02-28 2008-02-28 活性ポリオキサゾリンおよびそれを含む組成物

Country Status (6)

Country Link
US (1) US7943141B2 (cg-RX-API-DMAC7.html)
EP (1) EP2134181A4 (cg-RX-API-DMAC7.html)
JP (1) JP5615558B2 (cg-RX-API-DMAC7.html)
KR (2) KR101508621B1 (cg-RX-API-DMAC7.html)
CN (2) CN101686687A (cg-RX-API-DMAC7.html)
WO (1) WO2008106186A2 (cg-RX-API-DMAC7.html)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009043027A2 (en) * 2007-09-27 2009-04-02 Serina Therapeutics, Inc. Multi-armed forms of activated polyoxazoline and methods of synthesis thereof
US8101706B2 (en) 2008-01-11 2012-01-24 Serina Therapeutics, Inc. Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
DK3042922T3 (en) 2008-01-11 2017-10-23 Serina Therapeutics Inc MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COLPOLYMERS AND PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAME
US8637466B2 (en) 2008-08-11 2014-01-28 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
US20110318322A1 (en) 2009-01-12 2011-12-29 Nektar Therapeutics Conjugates of a Lysosomal Enzyme Moiety and a Water Soluble Polymer
ES2866674T3 (es) 2010-11-12 2021-10-19 Nektar Therapeutics Conjugados de una fracción de IL-2 y un polímero
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20140088021A1 (en) 2011-05-27 2014-03-27 Nektar Therapeutics Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds
US20160024252A1 (en) * 2011-08-03 2016-01-28 Anp Technologies, Inc. Oxazoline Polymer Compositions and Use Thereof
WO2013020079A2 (en) 2011-08-04 2013-02-07 Nektar Therapeutics Conjugates of an il-11 moiety and a polymer
US8383093B1 (en) * 2011-11-01 2013-02-26 Serina Therapeutics, Inc. Subcutaneous delivery of poly(oxazoline) conjugates
CN104271638B (zh) * 2012-03-16 2016-11-02 本德尔分析控股公司 源于亲核活性聚噁唑啉的交联聚合物和医用品
ES2879430T3 (es) 2012-11-15 2021-11-22 Apellis Pharmaceuticals Inc Análogos de compstatina de acción prolongada y composiciones y métodos relacionados
CN103897181B (zh) * 2012-12-27 2017-02-08 张昊 聚合物、其制备方法和应用
US9215876B2 (en) 2014-03-24 2015-12-22 International Business Machines Corporation 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom
US9624191B2 (en) 2014-03-24 2017-04-18 International Business Machines Corporation Cyclic carbonate monomers and ring opened polycarbonates therefrom
GB201405391D0 (en) * 2014-03-26 2014-05-07 Applied Biomimetic As Novel polymers and process for making membranes
MA39711A (fr) 2014-04-03 2015-10-08 Nektar Therapeutics Conjugués d'une fraction d'il-15 et d'un polymère
CN107075115B (zh) * 2014-07-18 2020-05-29 根特大学 一种用于制备均匀的高摩尔质量环亚氨醚聚合物的方法
KR20170046141A (ko) * 2014-07-31 2017-04-28 세리나 쎄라퓨틱스, 인코포레이티드 폴리옥사졸린 항체 약물 컨쥬게이트
KR102514142B1 (ko) 2014-10-06 2023-03-27 가트 테크놀로지스 비.브이. 조직-접착 다공성 지혈 제품
FI3359555T3 (fi) 2015-10-07 2024-03-20 Apellis Pharmaceuticals Inc Annostusohjeet
MX2018004296A (es) 2015-10-08 2018-08-01 Nektar Therapeutics Combinacion de un agonista selectivo de il-2rbeta y un agonista il-15 de accion prolongada.
JP2020516607A (ja) 2017-04-07 2020-06-11 アペリス・ファーマシューティカルズ・インコーポレイテッドApellis Pharmaceuticals,Inc. 投与レジメンならびに関連組成物および方法
WO2018213341A1 (en) 2017-05-15 2018-11-22 Nektar Therapeutics Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods
TW202426655A (zh) 2017-07-11 2024-07-01 美商新索思股份有限公司 非天然核苷酸之導入及其方法
US11622993B2 (en) 2017-08-03 2023-04-11 Synthorx, Inc. Cytokine conjugates for the treatment of autoimmune diseases
EP3502217B1 (en) * 2017-11-29 2020-05-27 Infineum International Limited Lubricating oil compositions
US10822569B2 (en) 2018-02-15 2020-11-03 Afton Chemical Corporation Grafted polymer with soot handling properties
TWI834636B (zh) 2018-02-26 2024-03-11 美商欣爍克斯公司 Il-15結合物及其用途
US10851324B2 (en) 2018-02-27 2020-12-01 Afton Chemical Corporation Grafted polymer with soot handling properties
CN110865055B (zh) * 2018-08-27 2022-10-25 香港科技大学 无金属偶联方法、偶联物及其应用
US10899989B2 (en) 2018-10-15 2021-01-26 Afton Chemical Corporation Amino acid grafted polymer with soot handling properties
KR20210091170A (ko) 2018-11-08 2021-07-21 신톡스, 인크. 인터류킨 10 접합체 및 이의 용도
US11046908B2 (en) 2019-01-11 2021-06-29 Afton Chemical Corporation Oxazoline modified dispersants
KR20210123299A (ko) 2019-02-06 2021-10-13 신톡스, 인크. Il-2 콘쥬게이트 및 이의 사용 방법
US12485181B2 (en) 2019-06-28 2025-12-02 Serina Therapeutics (Al), Inc. Polyoxazoline-drug conjugates with novel pharmacokinetic properties
JP7626404B2 (ja) * 2019-07-30 2025-02-04 ガット テクノロジーズ ビー.ブイ. カルシウム結合基を含むポリオキサゾリンコポリマー
JP7758662B2 (ja) 2019-09-10 2025-10-22 シンソークス, インコーポレイテッド Il-2コンジュゲートおよび自己免疫疾患を治療するための使用方法
AU2021259426B2 (en) 2020-04-22 2024-05-16 Merck Sharp & Dohme Corp. Human interleukin-2 conjugates biased for the interleukin-2 receptor beta gammac dimer and conjugated to a nonpeptidic, water-soluble polymer
KR20230144574A (ko) 2021-02-09 2023-10-16 세리나 쎄라퓨틱스, 인코포레이티드 폴리옥사졸린-지질 접합체, 및 이를 포함하는 지질 나노입자 및 제약 조성물
US20240398940A1 (en) 2021-09-03 2024-12-05 CureVac SE Novel lipid nanoparticles for delivery of nucleic acids
CN117940158A (zh) 2021-09-03 2024-04-26 库瑞瓦格欧洲公司 用于核酸递送的包含磷脂酰丝氨酸的新型脂质纳米颗粒
EP4422698A1 (en) 2021-10-29 2024-09-04 CureVac SE Improved circular rna for expressing therapeutic proteins
EP4469091A1 (en) 2022-01-28 2024-12-04 CureVac SE Nucleic acid encoded transcription factor inhibitors
JP2025504682A (ja) 2022-01-31 2025-02-14 ジェネバント サイエンシズ ゲーエムベーハー ポリ(アルキルオキサゾリン)-脂質コンジュゲートおよびそれを含む脂質粒子
CN114685784B (zh) * 2022-04-26 2023-09-15 北京清科胜因生物科技有限公司 一种用于核酸递送的聚(2-噁唑啉)脂质与脂质纳米颗粒及应用
CN114940756B (zh) * 2022-06-02 2023-11-07 北京清科胜因生物科技有限公司 一种聚(2-噁唑啉)脂质与脂质纳米颗粒及应用
WO2024098023A2 (en) 2022-11-04 2024-05-10 Sutro Biopharma, Inc. Interferon alpha polypeptides and conjugates
AU2024233180A1 (en) 2023-03-08 2025-09-25 CureVac SE Novel lipid nanoparticle formulations for delivery of nucleic acids
WO2024230934A1 (en) 2023-05-11 2024-11-14 CureVac SE Therapeutic nucleic acid for the treatment of ophthalmic diseases
WO2025158385A1 (en) 2024-01-25 2025-07-31 Genzyme Corporation Pegylated il-2 for suppressing adaptive immune response to gene therapy
EP4656669A1 (en) 2024-05-28 2025-12-03 Arkema France Fluorinated copolymers based on an oligo(2-oxazoline) macromonomer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2643403B2 (ja) * 1989-01-10 1997-08-20 花王株式会社 ポリ(n―アシルアルキレンイミン)系共重合体及びその用途
US5635571A (en) * 1995-06-30 1997-06-03 Cornell Research Foundation, Inc. Polymerizable macromonomers and polymers prepared therefrom
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
EP1395294A4 (en) * 2001-05-21 2006-01-11 Nektar Therapeutics PULMONARY ADMINISTRATION OF CHEMICALLY MODIFIED INSULIN
US6908963B2 (en) * 2001-10-09 2005-06-21 Nektar Therapeutics Al, Corporation Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
EP1436012B1 (en) * 2001-10-18 2017-12-20 Nektar Therapeutics Polymer conjugates of opioid antagonists
AU2003205384A1 (en) * 2002-02-01 2003-09-02 Intradigm Corporation Polymers for delivering peptides and small molecules in vivo
CA2558583C (en) * 2004-03-15 2013-07-09 Nektar Therapeutics Al, Corporation Polymer-based compositions and conjugates of hiv entry inhibitors
US8057821B2 (en) * 2004-11-03 2011-11-15 Egen, Inc. Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
WO2007026932A1 (ja) * 2005-09-01 2007-03-08 Japan Science And Technology Agency オキサゾリンのランダム共重合体

Similar Documents

Publication Publication Date Title
JP2010529212A5 (cg-RX-API-DMAC7.html)
JP2009521545A5 (cg-RX-API-DMAC7.html)
JP5514736B2 (ja) ポリオキサゾリン共重合体の多機能形態およびそれを含む薬物組成物
JP2016525466A5 (cg-RX-API-DMAC7.html)
JP2010535870A5 (cg-RX-API-DMAC7.html)
JP2004535485A5 (cg-RX-API-DMAC7.html)
JP2006520339A5 (cg-RX-API-DMAC7.html)
JP2012520247A5 (cg-RX-API-DMAC7.html)
WO2012086762A1 (ja) アミノ基含有ホスホリルコリン化合物及びその製造方法
JP2007077384A5 (cg-RX-API-DMAC7.html)
JPWO2021049504A5 (cg-RX-API-DMAC7.html)
JP2018507273A5 (cg-RX-API-DMAC7.html)
JP2010534246A5 (cg-RX-API-DMAC7.html)
JP2008095060A5 (cg-RX-API-DMAC7.html)
JP2010540488A5 (cg-RX-API-DMAC7.html)
JP2006225632A5 (cg-RX-API-DMAC7.html)
ES3022732T3 (en) Azide-functionalized copolymers
JP2008222908A5 (cg-RX-API-DMAC7.html)
JP2006524231A5 (cg-RX-API-DMAC7.html)
JP5853855B2 (ja) カルボキシル基含有ホスホリルコリン化合物及びその製造方法
EP1363878B1 (en) Process for preparing sulfamoyl-substituted phenethylamine derivatives
JP2017513885A5 (cg-RX-API-DMAC7.html)
JPWO2022215652A5 (cg-RX-API-DMAC7.html)
JP2013544876A5 (cg-RX-API-DMAC7.html)
JP2007154091A5 (cg-RX-API-DMAC7.html)